The only name listed on the filing is Lindy Fishburne, Breakout's managing director. Fishburne is also executive director of Breakout Labs, a project of the Thiel Foundation that provides cash and two years of networking and mentoring to early-stage companies in areas like food science and biomedicine.
Breakout Ventures' website is currently just a landing page. It says the firm is a "natural evolution" of Breakout Labs and "backs bold
The address given in the filing is the same as Breakout Labs' and Thiel
Breakout has already invested in several companies, including Immusoft, which is focused on technology for helping to treat genetic diseases, and Modern Meadow, which is